235 related articles for article (PubMed ID: 33044878)
1.
Mohammadzadeh R; Ghazvini K; Farsiani H; Soleimanpour S
Crit Rev Microbiol; 2021 Feb; 47(1):13-33. PubMed ID: 33044878
[TBL] [Abstract][Full Text] [Related]
2. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
Chae H; Shin SJ
J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles in mycobacteria: new findings in biogenesis, host-pathogen interactions, and diagnostics.
Salgueiro VC; Passemar C; Vázquez-Iniesta L; Lerma L; Floto A; Prados-Rosales R
mBio; 2024 May; 15(5):e0255223. PubMed ID: 38567992
[TBL] [Abstract][Full Text] [Related]
4. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design.
Karbalaei Zadeh Babaki M; Soleimanpour S; Rezaee SA
Microb Pathog; 2017 Nov; 112():20-29. PubMed ID: 28942172
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in Mycobacteria and Tuberculosis.
Mehaffy C; Ryan JM; Kruh-Garcia NA; Dobos KM
Front Cell Infect Microbiol; 2022; 12():912831. PubMed ID: 35719351
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles Released from
Alvarez-Jiménez VD; Leyva-Paredes K; García-Martínez M; Vázquez-Flores L; García-Paredes VG; Campillo-Navarro M; Romo-Cruz I; Rosales-García VH; Castañeda-Casimiro J; González-Pozos S; Hernández JM; Wong-Baeza C; García-Pérez BE; Ortiz-Navarrete V; Estrada-Parra S; Serafín-López J; Wong-Baeza I; Chacón-Salinas R; Estrada-García I
Front Immunol; 2018; 9():272. PubMed ID: 29520273
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles in the context of Mycobacterium tuberculosis infection.
Palacios A; Gupta S; Rodriguez GM; Prados-Rosales R
Mol Immunol; 2021 May; 133():175-181. PubMed ID: 33743266
[TBL] [Abstract][Full Text] [Related]
8. Significance of extracellular vesicles in orchestration of immune responses in
Alipoor SD; Elieh-Ali-Komi D
Front Cell Infect Microbiol; 2024; 14():1398077. PubMed ID: 38836056
[No Abstract] [Full Text] [Related]
9. Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis.
García-Martínez M; Vázquez-Flores L; Álvarez-Jiménez VD; Castañeda-Casimiro J; Ibáñez-Hernández M; Sánchez-Torres LE; Barrios-Payán J; Mata-Espinosa D; Estrada-Parra S; Chacón-Salinas R; Serafín-López J; Wong-Baeza I; Hernández-Pando R; Estrada-García I
Int J Nanomedicine; 2019; 14():6707-6719. PubMed ID: 31692512
[TBL] [Abstract][Full Text] [Related]
10. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
11. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
12. A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.
Ahmed M; Smith DM; Hamouda T; Rangel-Moreno J; Fattom A; Khader SA
Vaccine; 2017 Sep; 35(37):4983-4989. PubMed ID: 28774560
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterial extracellular vesicles and host pathogen interactions.
Gupta S; Rodriguez GM
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29722822
[TBL] [Abstract][Full Text] [Related]
14. Classification and characterisation of extracellular vesicles-related tuberculosis subgroups and immune cell profiles.
Zhou P; Shen J; Ge X; Ding F; Zhang H; Huang X; Zhao C; Li M; Li Z
J Cell Mol Med; 2023 Sep; 27(17):2482-2494. PubMed ID: 37409682
[TBL] [Abstract][Full Text] [Related]
15. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
Fletcher HA; Dockrell HM
Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines.
Yadav J; Verma S; Chaudhary D; Jaiwal PK; Jaiwal R
Curr Pharm Biotechnol; 2019; 20(6):446-458. PubMed ID: 31208308
[TBL] [Abstract][Full Text] [Related]
17. A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis.
Dhanda SK; Vir P; Singla D; Gupta S; Kumar S; Raghava GP
PLoS One; 2016; 11(4):e0153771. PubMed ID: 27096425
[TBL] [Abstract][Full Text] [Related]
18. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis infection and vaccine development.
Tang J; Yam WC; Chen Z
Tuberculosis (Edinb); 2016 May; 98():30-41. PubMed ID: 27156616
[TBL] [Abstract][Full Text] [Related]
20. Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine.
Lee JW; Parlane NA; Rehm BHA; Buddle BM; Heiser A
Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 28087528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
